findmyKOL

Ashis Tayal, MD

Basic profile

Vascular Neurology

ORCIDNPI
RegionMarietta, GA · SoutheastSpecialtyVascular NeurologyFocusNeurology
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ashis Tayal is a Neurology physician. OpenAlex indexes 99 publications with 2,799 citations (h-index 24).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
99publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,799citations

Total citations across indexed works.

24h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

677 Church St NE
Marietta, GA 300601101

Telephone

770-422-2326

Provider last certified this registry record 31 Oct 2023.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    62.4%
    Statin32.7%
    Atorvastatin Calcium56%Rosuvastatin Calcium44%
    Part D51 patients
    Calcium channel blocker11.1%
    Amlodipine Besylate100%
    Part D29 patients

    + 5 more classes in this area

  • Blood & clotting

    25.5%
    P2Y12 inhibitor15%
    Clopidogrel100%
    Part D41 patients
    Factor Xa inhibitor10.5%
    Eliquis100%
    Part D19 patients
  • Nervous system

    12.1%
    Other antiepileptics6%
    Levetiracetam100%
    Part D<11 patients
    N-methyl-D-aspartate Receptor Antagonist4.4%
    Memantine Hcl100%
    Part D<11 patients

    + 1 more class in this area

Where care is delivered (Part B)14.2% facility · 85.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”